• 4-for-1 Split Effective July 1: CrowdStrike's split timing coincides with a period of exceptionally strong underlying fundamental performance.
• CrowdStrike CEO Sale: CEO George Kurtz sold approximately $3.4 million in shares on June 25, drawing some bearish attention.
• Rivian Leans on Production Scaling: Rivian is gaining on anticipation of its Q2 delivery report as R2 SUV deliveries ramp toward 2026 guidance.
• Promotion Winners See Inflows: Nextpower and Southern Copper benefited from promotion into growth or large-cap benchmarks.
• Dramatic SanDisk Target Increase: Bernstein hiked its target on SanDisk to $3,000 from $1,700, one of the largest single increases of the period.
• KLA Corporation Leads in Short Interest: Short interest above 36% of float has amplified KLA's upside moves following positive catalysts.
• FDA Regulatory Acceptance for Sarepta: The FDA accepted supplemental applications for Sarepta's Duchenne treatments, setting a clear PDUFA timeline.
• Shared Medicare Policy Catalyst: Both companies face the same Bridge program covering their respective GLP-1 drugs at a $50 monthly copay.
• Viasat Surges on Spectrum Valuation Thesis: A bullish Oppenheimer spectrum valuation thesis drove a 24% single-day gain for Viasat.
• Kunlunxin Targets Hong Kong IPO: The AI chip affiliate is reportedly targeting a listing that could value the business at approximately $50 billion.